| Sign In to gain access to subscriptions and/or personal tools. |
Pathophysiology of Pulmonary Arterial HypertensionSection of Pulmonary/Critical Care Medicine, Ochsner Foundation Clinic, Jefferson
Department of Cardiology, Ochsner Foundation Clinic, Jefferson
Section of Pulmonary/Critical Care Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, bdeboi{at}lsuhsc.edu The mechanisms leading to elevations in precapillary pulmonary vascular resistance are complex and likely involve multiple pathways, but the histopathologic sequelae of these processes are restricted to a few findings, primarily neoangiogenesis, intimal and smooth muscle proliferation, vasoconstriction, and/or in situ thrombosis. Regardless of the etiology of pulmonary hypertension, abnormalities in endothelial function are often observed and likely play a central role in mediating structural changes.
Key Words: pulmonary arterial hypertension nitric oxide pathway endothelial disfunction
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 11, No. 2,
104-109 (2007) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

